Insys Therapeutics, Inc. to Present at Two Upcoming Conferences in June
27 May 2016 - 6:30AM
Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY)
today announced that Darryl Baker, Chief Financial Officer, and
Santosh Vetticaden, MD, PhD, Senior Vice President and Chief
Medical Officer, will present at two upcoming conferences in June
as follows:
Event: |
|
Jefferies 2016 Healthcare Conference |
Date: |
|
Thursday, June 9, 2016 |
Time: |
|
3:00 p.m. Eastern Time |
|
|
|
Event: |
|
JMP Securities 2016 Life Sciences Conference |
Date: |
|
Wednesday, June 22, 2016 |
Time: |
|
2:00 p.m. Eastern Time |
Location: |
|
The St. Regis, New York |
|
|
|
The presentations will be webcast live at the aforementioned
times as well as archived for 90 days thereafter, via the Company’s
website at www.insysrx.com, under the Investors Section.
About Insys Therapeutics, Inc.Insys
Therapeutics is a specialty pharmaceutical company that develops
and commercializes innovative drugs and novel drug delivery systems
of therapeutic molecules that improve the quality of life of
patients. Using proprietary sublingual spray technology and
capabilities to develop pharmaceutical cannabinoids, Insys
addresses the clinical shortcomings of existing commercial
products. Insys currently markets one product: Subsys® (fentanyl
sublingual spray). The Company recently submitted a New Drug
Application to the U.S. Food and Drug Administration for Syndros™
(dronabinol oral solution), a proprietary, orally administered
liquid formulation of dronabinol that Insys believes has distinct
advantages over the current formulation of dronabinol in soft gel
capsule. Insys is developing a pipeline of sublingual sprays, as
well as pharmaceutical cannabidiol.
Subsys® and Syndros™ are registered trademarks of Insys
Therapeutics, Inc.
Investor Contact:
Lisa M. Wilson, President
In-Site Communications, Inc.
Phone: 212-452-2793
Email: lwilson@insitecony.com
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Apr 2024 to May 2024
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Insys Therapeutics, Inc. (NASDAQ): 0 recent articles
More News Articles